These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11139313)

  • 1. p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression.
    Creaney J; McLaren BM; Stevenson S; Musk AW; de Klerk N; Robinson BW; Lake RA
    Br J Cancer; 2001 Jan; 84(1):52-6. PubMed ID: 11139313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
    Qiu LL; Hua PY; Ye LL; Wang YC; Qiu T; Bao HZ; Wang L
    Cancer Detect Prev; 2007; 31(1):45-9. PubMed ID: 17292563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of serum anti-p53 antibodies in patients with various types of cancer].
    Sakai H
    Rinsho Byori; 2002 Jan; 50(1):90-2. PubMed ID: 11871143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
    Huober J; Sprenger H; Costa SD; Zentgraf H; Schmid H; Kaufmann M; Bastert G
    Zentralbl Gynakol; 1996; 118(10):560-4. PubMed ID: 8999710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
    Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
    Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
    Lenner P; Wiklund F; Emdin SO; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
    Br J Cancer; 1999 Feb; 79(5-6):927-32. PubMed ID: 10070892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.
    Castelli M; Cianfriglia F; Manieri A; Palma L; Pezzuto RW; Falasca G; Delpino A
    Anticancer Res; 2001; 21(1B):753-8. PubMed ID: 11299839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody formation to cellular p53 protein in patients with squamous cell carcinomas of the upper respiratory and digestive system].
    Maass JD; Gottschlich S; Lippert BM; Niemann AM; Görögh T; Werner JA
    Laryngorhinootologie; 1996 Jan; 75(1):53-6. PubMed ID: 8851121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of antibodies against p53 in patients with oral squamous cell carcinoma--five years survival rate].
    Hofele C; Schwager-Schmitt M; Volkmann M
    Laryngorhinootologie; 2002 May; 81(5):342-5. PubMed ID: 12001023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to p53 in sera of patients with autoimmune thyroid disease.
    Fenton CL; Patel A; Tuttle RM; Francis GL
    Ann Clin Lab Sci; 2000 Apr; 30(2):179-83. PubMed ID: 10807162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancer.
    Gadducci A; Ferdeghini M; Buttitta F; Fanucchi A; Annicchiarico C; Prontera C; Bevilacqua G; Genazzani AR
    Anticancer Res; 1996; 16(6B):3519-23. PubMed ID: 9042215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.
    Forslund A; Kressner U; Lindmark G; Inganäs M; Lundholm K
    Int J Oncol; 2001 Sep; 19(3):501-6. PubMed ID: 11494027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
    Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
    Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.
    Müller M; Meyer M; Schilling T; Ulsperger E; Lehnert T; Zentgraf H; Stremmel W; Volkmann M; Galle PR
    Int J Oncol; 2006 Oct; 29(4):973-80. PubMed ID: 16964393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical importance of serum anti-p53 antibodies as tumor markers].
    Sakai H; Okamoto E
    Rinsho Byori; 2002 Oct; 50(10):970-5. PubMed ID: 12451677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of p53 autoantibodies in the serum of patients with breast cancer.
    Willsher PC; Pinder SE; Robertson L; Nicholson RI; Ellis IO; Bell JA; Blamey RW; Green JA; Robertson JF
    Anticancer Res; 1996; 16(2):927-30. PubMed ID: 8687153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases.
    Neri M; Betta P; Marroni P; Filiberti R; Cafferata M; Mereu C; Ivaldi G; Montanaro F; Puntoni R; Paganuzzi M
    Lung Cancer; 2003 Feb; 39(2):165-72. PubMed ID: 12581569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pattern and prognostic implications of anti-p53 in hepatocellular carcinoma.
    Akere A; Otegbayo JA
    Singapore Med J; 2007 Jan; 48(1):41-4. PubMed ID: 17245515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.